Royalty Pharma Plc

RPRX

Royalty Pharma is a biopharmaceutical company based in New York City that purchases economic interests in marketed and late stage biopharmaceutical products from life sciences organizations. Royalty Pharma funds innovation in life sciences both directly and indirectly: directly when it partners with life sciences companies to co-develop and co-fund products in late-stage clinical trials, and indirectly when it acquires existing royalty interests from the original innovators (academic institutions, research hospitals, foundations and inventors).

Royalty Pharma Plc has been a target of short sellers for a while. The current short interest of 2.67% is roughly at the average of the last 12 months (3.60%).